Optitrin 20 mg, 5 mg Ophthalmic Solution
PDF Leaflet Revision Date: 28 March 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of elevated intra-ocular pressure in glaucoma and ocular hypertension.
Dosage (summary)
One drop in the affected eye(s) twice daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not established for safety in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- Calcium channel blockers
- Beta-adrenergic blocking agents
- Oral carbonic anhydrase inhibitors
Contraindications
- Hypersensitivity to components
- Reactive airway disease
- Severe renal impairment
- Severe cardiac conditions
Common side effects
- Burning and stinging
- Blurred vision
- Taste perversion
- Headache
Counselling Points
- Do not wear contact lenses during application
- Monitor for signs of allergic reactions
- Avoid driving if vision is affected
Serious warnings
- Systemic absorption may cause respiratory and cardiovascular reactions
- Caution in patients with asthma or COPD
Important Disclaimer
The Optitrin 20 mg, 5 mg Ophthalmic Solution professional information leaflet below is the property of Trinity Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
